title: Tricyclic antidepressant immunoassays may reflect quetiapine adherence.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Cerullo
authors.forename: Allison A
authors.initials: AA
authors.lastname: Albertz
authors.forename: Jennifer N
authors.initials: JN
authors.lastname: Bell
authors.forename: Robert M
authors.initials: RM
authors.lastname: Anthenelli
authors.forename: Melissa P
authors.initials: MP
authors.lastname: Delbello
mesh_terms: D000293:Adolescent; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000453:epidemiology*; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007118:Immunoassay; D002189:Marijuana Abuse / Q000453:epidemiology*; D010349:Patient Compliance / Q000706:statistics & numerical data*; D000069348:Quetiapine Fumarate; D000077236:Topiramate
chemical_list: D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000077236:Topiramate; D000069348:Quetiapine Fumarate; D005632:Fructose